1. Home
  2. |Insights
  3. |Minimizing Risks When Launching Smart Medical Devices

Minimizing Risks When Launching Smart Medical Devices

Event | 03.09.23, 1:00 PM EST - 2:00 PM EST

More companies than ever before are launching smart medical devices and industry growth seems endless as new products and technologies are announced daily. However, before companies push products to market, it’s crucial to understand key aspects of device approval, and company and patient protection. In this webinar, our speakers will outline intellectual property strategies, U.S. Food and Drug Administration considerations, and data cybersecurity concerns that are inherent to all smart medical devices. They will explore the legal issues that can significantly decrease the risk profile and potential liabilities throughout a product's lifecycle and create safer, more reliable products for consumers.

For more information, please visit these areas: Intellectual Property, Intellectual Property Litigation, Mass Tort, Product, and Consumer Litigation, Privacy and Cybersecurity, Medical Devices, Patent Litigation, Life Sciences

Participants

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.